Sen. Kelly Defends Women's Freedom to Make Own Decisions About Abortion in Brief to Supreme Court
April 19, 2023
April 19, 2023
WASHINGTON, April 19 -- Sen. Mark Kelly, D-Arizona, issued the following news release:
Last week, Arizona Senator Mark Kelly joined 252 members of the House and Senate in signing a brief in support of upholding the Food and Drug Administration's (FDA) longstanding authority to approve and regulate mifepristone--an abortion and miscarriage management medication that has been used safely and effectively for over 20 years.
In the brief, Kelly and other lawmakers wrote . . .
Last week, Arizona Senator Mark Kelly joined 252 members of the House and Senate in signing a brief in support of upholding the Food and Drug Administration's (FDA) longstanding authority to approve and regulate mifepristone--an abortion and miscarriage management medication that has been used safely and effectively for over 20 years.
In the brief, Kelly and other lawmakers wrote . . .